Literature DB >> 3580270

Oestrogen and progesterone receptor distribution in the cancerous breast.

C Panahy, J R Puddefoot, E Anderson, G P Vinson, C L Berry, M J Turner, C L Brown, A W Goode.   

Abstract

To test the hypothesis that steroid hormone receptor expression is particularly pronounced in breast tumours when compared with non-neoplastic tissue, mastectomy samples were divided into 16 sectors. Multifocal tumours, of varying receptor phenotype were found in 4 patients and in addition different regions of large tumours also showed varying receptor contents. Remaining samples were found to consist of normal tissue, with fat, connective tissue and some benign breast disease. In the 9 patients with oestrogen receptor positive tumours (ER), ER content was invariably much greater in the tumours than in the remainder of the breast. Progesterone receptor (PR) content was not closely related to ER, and was lowest in the poorly differentiated tumours. This relation to differentiation was not seen in ER. The data support the view that ER concentration in ER positive tumours may reflect the transformed nature of neoplastic tissue.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3580270      PMCID: PMC2001706          DOI: 10.1038/bjc.1987.90

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  Factors influencing the estimation of oestrogen receptors in human malignant breast tumours.

Authors:  H Braunsberg
Journal:  Eur J Cancer       Date:  1975-07       Impact factor: 9.162

2.  Malignant and benign human mammary disease: estrogen binding in relation to clinical data.

Authors:  L Terenius; H Johansson; A Rimsten; L Thorén
Journal:  Cancer       Date:  1974-05       Impact factor: 6.860

3.  The binding of estradiol-17beta to human breast cancers and other tissues in vitro.

Authors:  H Johansson; L Terenius; L Thorén
Journal:  Cancer Res       Date:  1970-03       Impact factor: 12.701

4.  Intratumoral variation of cytoplasmic and nuclear estrogen receptor concentrations in human mammary carcinoma.

Authors:  C Silfverswärd; L Skoog; S Humla; S A Gustafsson; B Nordenskjöld
Journal:  Eur J Cancer       Date:  1980-01       Impact factor: 9.162

5.  Estrogen receptor values in patients with benign breast disease.

Authors:  J C Allegra; M E Lippman; L Green; A Barlock; R Simon; E B Thompson; K K Huff; W Griffin
Journal:  Cancer       Date:  1979-07       Impact factor: 6.860

6.  Sex steroid receptor concentration in breast carcinoma tissue: effect of devascularization during mastectomy.

Authors:  G S Leight; S A Wells; K S McCarty
Journal:  Surgery       Date:  1984-03       Impact factor: 3.982

7.  Hormones as cancer growth factors.

Authors:  L Israel; P Band
Journal:  Lancet       Date:  1984-10-13       Impact factor: 79.321

8.  Relationships between steroid receptor and epithelial cell proliferation in benign fibrocystic disease of the breast.

Authors:  J D Jacquemier; P H Rolland; D Vague; R Lieutaud; J M Spitalier; P M Martin
Journal:  Cancer       Date:  1982-06-15       Impact factor: 6.860

9.  Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors.

Authors:  W J King; E R DeSombre; E V Jensen; G L Greene
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701

Review 10.  Hormone receptors. An update and application.

Authors:  C A Hubay; B Arafah; N H Gordon; S P Guyton; J P Crowe
Journal:  Surg Clin North Am       Date:  1984-12       Impact factor: 2.741

View more
  4 in total

1.  Bile acid receptors and large bowel cancer.

Authors:  C L Berry
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

2.  Effects of danazol on incidence of progesterone and oestrogen receptors in benign breast disease.

Authors:  C Panahy; J R Puddefoot; E Anderson; G P Vinson; C L Berry; M J Turner; C L Brown; A W Goode
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-22

Review 3.  ER re-expression and re-sensitization to endocrine therapies in ER-negative breast cancers.

Authors:  Joeli A Brinkman; Dorraya El-Ashry
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-03-05       Impact factor: 2.673

4.  Epidermal growth factor receptor and oestrogen receptors in the non-malignant part of the cancerous breast.

Authors:  S Barker; C Panahy; J R Puddefoot; A W Goode; G P Vinson
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.